Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 08 06 2018
accepted: 03 09 2018
pubmed: 18 12 2018
medline: 30 7 2019
entrez: 18 12 2018
Statut: ppublish

Résumé

The prevalence of frailty has been widely researched in the elderly population. However, data about people of working age are scarce. The aim of this paper was to assess the prevalence of prefrailty and frailty in rheumatoid arthritis (RA) patients of working age, and to assess factors associated with prefrailty/frailty. In this monocentric cross-sectional study, 100 RA patients aged 18-65 years were included. Frailty was measured with the Frailty Instrument for Primary Care of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) and disease activity with the Clinical Disease Activity Index (CDAI). In addition, disease duration (years), pain intensity (visual analogue scale) and employment status were also assessed. Fifty-five percent were robust, 30% prefrail and 15% were frail. Eighty-nine of the prefrail/frail individuals suffered from exhaustion. Compared to robust individuals, the prefrail/frail individuals had significantly higher median scores in disease activity [4.0 (Q25-Q75: 0-10) vs. 11 (Q25-Q75: 6-18)] and pain intensity [3.0 (Q25-Q75: 2.0-4.0) vs. 4.0 (Q25-Q75: 2.8-6.3)] and a higher rate of unemployment [31% vs. 53%]. In the multivariable analysis, higher disease activity (ß=0.444; p<0.001), unemployment (ß=0.243; p=0.005), higher pain intensity (ß=0.186; p=0.060) and longer disease duration (ß=0.181; p=0.020) were associated with a higher frailty score. Frailty is common in RA patients, even those of working age. As the prevalence of frailty increases with age, it is important to take this syndrome into account in younger persons and to take action to counteract frailty.

Identifiants

pubmed: 30557129
pii: 13053

Types de publication

Journal Article

Langues

eng

Pagination

585-592

Auteurs

Sandra Haider (S)

Department of Social and Preventive Medicine, Centre of Public Health, Medical University of Vienna, Austria.

Igor Grabovac (I)

Department of Social and Preventive Medicine, Centre of Public Health, Medical University of Vienna, Austria. igor.grabovac@meduniwien.ac.at.

Carolin Berner (C)

Department of Rheumatology and Osteology, Kaiser Franz Josef Hospital, SMZ Süd, Vienna, Austria.

Thomas Lamprecht (T)

Karl Landsteiner Institute for Autoimmune Diseases and Rheumatology, Vienna, Austria.

Karl-Heinrich Fenzl (KH)

Karl Landsteiner Institute for Autoimmune Diseases and Rheumatology, Vienna, Austria.

Ludwig Erlacher (L)

Department of Rheumatology and Osteology, Kaiser Franz Josef Hospital, SMZ Süd, Vienna; and Karl Landsteiner Institute for Autoimmune Diseases and Rheumatology, Vienna, Austria.

Michael Quittan (M)

Karl Landsteiner Institute for Physical Medicine and Rehabilitation, and Department of Physical Medicine and Rehabilitation, Kaiser Franz Josef-Hospital, SMZ Süd, Vienna, Austria.

Thomas E Dorner (TE)

Department of Social and Preventive Medicine, Centre of Public Health, Medical University of Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH